The major U.S. equity indexes all finished lower for the week ended November 6, with technology shares bearing the brunt of the selling. The Nasdaq Composite dropped 3.4%, the S&P 500 lost 2.7%, and the Dow Jones Industrial Average slipped 0.9%. Investors grappled with renewed questions about artificial intelligence valuations, the scale of infrastructure spending, and whether growth expectations can be sustained. The Zacks approach to beat the markets draws attention to specific stocks that have delivered strong returns despite the broader pullback, including Ulta Beauty, Accenture, and HCA Healthcare.
AI Worries and Election Outcome Add Pressure
The technology-heavy Nasdaq took the hardest hit as investors reassessed the lofty valuations assigned to AI-related companies and the massive sums being poured into infrastructure. The midterm election results introduced another layer of uncertainty, with Democratic victories raising concerns about potentially tighter regulations and possible restrictions on data center construction. Those factors, combined with elevated valuations and doubts about the payback on AI investments, intensified selling pressure across the market.
A partial rebound on Friday trimmed the weekly losses as technology shares recovered and investors digested a stronger-than-expected October employment report. Payroll gains topped forecasts, and the unemployment rate fell to 4.1%. While the jobs data signaled a resilient labor market, it also stoked worries that the Federal Reserve might keep monetary policy restrictive or even consider another rate hike.
Zacks Rank Upgrades Deliver Strong Gains
Even in a difficult market, the Zacks Rank system has identified stocks that moved sharply higher after being upgraded to Strong Buy. Howard Hughes Holdings Inc. (HHH) has climbed 26.31% since its upgrade on September 18, while the S&P 500 fell 3.3% over the same period. Telos Corporation (TLS), upgraded on September 16, has returned 14% while the S&P 500 declined 2.7%.
The Zacks #1 Rank portfolio has outperformed the S&P 500 by 2.3 percentage points this year. Through August 3, the portfolio returned 12.08%, compared with a 9.78% gain for the S&P 500 and 10.41% for the equal-weight version of the index. Since its inception in 1988, the portfolio has beaten the market by 12.4 percentage points, with an average annual return of 23.9% through August 3. That compares with 11.5% for the S&P 500 and 11.3% for the equal-weight index.
Recommendation Upgrades: Concentra and BP
Zacks Recommendation upgrades to Outperform have also paid off. Concentra Group Holdings Parent, Inc. (CON) has surged 23.2% since its upgrade on August 31, while the S&P 500 fell 4.4%. BP p.l.c. (BP) has gained 1.6% since its September 8 upgrade, against a 4.6% decline for the S&P 500. The Zacks Recommendation is designed to predict performance over the next 6 to 12 months and classifies stocks as Outperform, Neutral, or Underperform.
Focus List Standouts: HCA Healthcare and Ulta Beauty
Two holdings from the Zacks Focus List have posted impressive gains over the past 12 weeks. HCA Healthcare, Inc. (HCA), added to the list on January 7, 2019, has soared 21.1%. Ulta Beauty, Inc. (ULTA), a Focus List member since March 25, 2020, has returned 19.7%. Over the same period, the S&P 500 declined 4.3%.
The 50-stock Focus List portfolio returned 19.86% in the year-to-date period through August 31, 2026, versus 13.14% for the S&P 500 and 15.59% for the equal-weight index. In 2025, the portfolio gained 22.1%, compared with 17.9% for the S&P 500 and 11.4% for the equal-weight version. The portfolio returned 18.41% in 2024, 29.54% in 2023, and -15.2% in 2022, when the S&P 500 fell 17.96%.
ECAP Holdings: Accenture and FactSet
Accenture plc (ACN), a component of the Earnings Certain Admiral Portfolio (ECAP), has jumped 52.2% over the past 12 weeks, while FactSet Research Systems Inc. (FDS) has returned 19.4%. ECAP is a 30-stock portfolio of ultra-defensive, long-term buy-and-hold companies selected for their earnings stability through recessions.
The portfolio returned -9.4% in the first half of 2026 through June 30, versus a 10.2% gain for the S&P 500. For 2025, ECAP returned -1.67% against a 17.9% gain for the S&P 500. In 2024, the portfolio gained 16.26% while the S&P 500 rose 24.89%, and in 2023 it returned 12.17% versus 26.28% for the index. ECAP lost 4.7% in 2022, a year when the S&P 500 fell 17.96%.
ECDP: Procter & Gamble and Automatic Data
The Earnings Certain Dividend Portfolio (ECDP) has also delivered gains. Procter & Gamble Company (PG) has returned 12.5% over the past 12 weeks, and Automatic Data Processing, Inc. (ADP) has climbed 10.9%. The portfolio, which holds 25 stocks with extremely low beta and a history of minimal earnings variability over more than 20 years, is designed to mitigate risk.
ECDP returned -1.7% in the first half of 2026 through June 30, compared with a 10.2% gain for the S&P 500 and 9.03% for the Dividend Aristocrats ETF (NOBL). In 2025, the portfolio lost 0.6% while NOBL gained 6.8%. For full-year 2024, ECDP returned 6.95% versus 24.89% for the S&P 500 and 6.72% for NOBL. The portfolio returned -0.9% in 2023 and -2.3% in 2022, when NOBL fell 8.34%.
Top 10 Stocks: FirstCash Holdings
FirstCash Holdings, Inc. (FCFS), a member of the Zacks Top 10 Stocks for 2025, has gained 18.4% since January 5, 2026, while the S&P 500 rose 7.7%. The Top 10 portfolio returned 15% in the year-to-date period through August 31, 2026, versus 12.9% for the S&P 500 and 14.8% for the equal-weight index. In 2025, the portfolio gained 22.6%, and in 2024 it surged 62.98%. Since 2012 through August 2026, the Top 10 portfolio has produced a cumulative return of 2,881.3%, compared with 648.5% for the S&P 500 and 481.7% for the equal-weight index.
